logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
K

Kohei Shitara

National Cancer Center Hospital East

79H-index
1.1KPaper Count
3.5WCitation Count
Published Papers 274
Publication Date
logo
Author's Reply: Neutrophil-Macrophage Interactions in Gastric Cancer
errCancer Science
IF4.3
err2026-08-25
err0
errOAAI
errKeita H. Nagaoka; Hiroki Yamashita; Chiaki Mashima; Guoqiang Zhang; Hitoshi Saito; Tatsunori Minamide; Takuya Nakatsuru; Ryo Kamata; Shunsuke A. Sakai; Gaku Yamamoto; Tomoko Y. Morita; Kazuki Nakai; Yumi Hakozaki; Kumi Kinoshita; Yui Takahashi; Izuma Nakayama; Akihito Kawazoe; Sai M. Pulukuri; Yuko Ishii; Hiroshi Haeno; Yukie Kashima; Kohei Shitara; Tomonori Yano; Takeshi Saito; Akihiro Ohashi
errShare
errSave
Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies
errESMO Open
IF8.3
err2026-05-26
err0
errOAAI
errS.B. Maron; R.-H. Xu; Z.A. Wainberg; S.Y. Rha; Y. Zhang; F. Pietrantonio; S.C.S. Oliveira; Y. Li; M.-H. Chen; K. Korphaisarn; E. Elimova; C.A. Calderon; F.V. Herpe; W.P. Yong; T.M. Dos Santos; M. Tan; K. Isse; R.E. Yanes; K. Shitara
errShare
errSave
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer
errCancer Science
IF4.3
err2026-05-21
err0
errOAAI
errTakuya Nakatsuru; Hiroki Yamashita; Chiaki Mashima; Guoqiang Zhang; Hitoshi Saito; Tatsunori Minamide; Keita H. Nagaoka; Ryo Kamata; Shunsuke A. Sakai; Gaku Yamamoto; Tomoko Y. Morita; Kazuki Nakai; Yumi Hakozaki; Kumi Kinoshita; Yui Takahashi; Izuma Nakayama; Akihito Kawazoe; Yuko Ishii; Sai M. Pulukuri; Hiroshi Haeno; Yukie Kashima; Kohei Shitara; Tomonori Yano; Takeshi Saito; Akihiro Ohashi
errShare
errSave
Neutrophil-Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo-Immunotherapy
errCancer Science
IF4.3
err2026-05-21
err0
errOAAI
errKeita H. Nagaoka; Hiroki Yamashita; Chiaki Mashima; Guoqiang Zhang; Hitoshi Saito; Tatsunori Minamide; Takuya Nakatsuru; Ryo Kamata; Shunsuke A. Sakai; Gaku Yamamoto; Tomoko Y. Morita; Kazuki Nakai; Yumi Hakozaki; Kumi Kinoshita; Yui Takahashi; Izuma Nakayama; Akihito Kawazoe; Sai M. Pulukuri; Yuko Ishii; Hiroshi Haeno; Yukie Kashima; Kohei Shitara; Tomonori Yano; Takeshi Saito; Akihiro Ohashi
errShare
errSave
Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons
errNature Reviews Clinical Oncology
IF82.2
err2026-05-15
err0
PREAI
errHongcheng Zhu; Florian Lordick; Yelena Y. Janjigian; Sun Young Rha; Magnus Nilsson; Kohei Shitara; Richard Owen; Zhen Zhang; Elizabeth C. Smyth
errShare
errSave
Zolbetuximab plus chemotherapy in Japanese patients with claudin 18.2–positive gastric or gastroesophageal junction adenocarcinoma: a combined subgroup analysis of the phase 3 SPOTLIGHT and GLOW trials
errGastric Cancer
IF5.1
err2026-05-07
err0
errOAAI
errKensei Yamaguchi; Hirokazu Shoji; Hisateru Yasui; Eiji Oki; Daisuke Sakai; Tetsuya Hamaguchi; Akihito Tsuji; Takashi Oshima; Masahiro Tsuda; Keiko Minashi; Jianning Yang; Abraham Guerrero; Yoko Ueno; Maria Matsangou; Georgia Gourgioti; Yuka Nakanishi; Satomi Furuki; Kana Kuwamoto; Shunsuke Yamada; Kohei Shitara
errShare
errSave
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
errNature Medicine
IF50
err2026-03-16
err0
errOAAI
errKohei Shitara; Hirokazu Shoji; Nicola Fazio; Sara Lonardi; Keun-Wook Lee; Li-Yuan Bai; Kensei Yamaguchi; Jean-Philippe Metges; Gianluca Masi; Denis Smith; Tae-Yong Kim; Maria Matsangou; Archita Shrivastava; Miaomai Zhou; Jason Hill; Abraham Guerrero; Xuewei Wang; Aziz Zaanan; Samuel J. Klempner
errShare
errSave
Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma☆
errESMO Open
IF8.3
err2026-02-26
err0
errOAAI
errK. Shitara; Y.-J. Bang; L.S. Wyrwicz; S.Y. Rha; T. Oshima; F. Pietrantonio; Y.-K. Park; S. Lonardi; P. Yañez; C.-J. Yen; J.-P. Metges; M. Garrido; M. Moehler; S. Pelles-Avraham; W.P. Yong; A. Spallanzani; E. Jensen; R. Krishnan; C.-S. Shih; S.-E. Al-Batran
errShare
errSave
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649
errAnnals of Oncology
IF65.4
err2026-02-11
err0
PREAI
errY.Y. Janjigian; K. Shitara; J.A. Ajani; L. Shen; M. Garrido; C. Gallardo; L. Wyrwicz; K. Yamaguchi; J.M. Cleary; E. Elimova; R. Bruges; M. Karamouzis; T. Skoczylas; A. Bragagnoli; T. Liu; M. Tehfe; T. Zander; R. Kowalyszyn; R. Pazo-Cid; M. Schenker
errShare
errSave
Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies
errESMO Open
IF8.3
err2026-01-08
err0
errOAAI
errK. Shitara; E. Smyth; F. Lordick; R. Pophale; C. Matney; M. Matsangou; G. Gourgioti; M. Oh; R. Ranganath; S.J. Klempner
errShare
errSave
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies
errONCOLOGIST
IF4.2
err2026-01-01
err0
PREAI
errPark, Yeon Hee; Cortes, Javier; Modi, Shanu; Hurvitz, Sara A.; Bianchini, Giampaolo; Iwata, Hiroji; Shitara, Kohei; Siena, Salvatore; Goto, Yasushi; Ku, Geoffrey Y.; Powell, Charles A.; Swain, Sandra M.; Arunachalam, Meena; Janek, Martin; Cheng, Yingkai; Chu, Changan; Verma, Purnima; Kuptsova-Clarkson, Nataliya; Mathias, Elton; Goodman, Erin; Rugo, Hope S.
errShare
errSave
ASO Visual Abstract: Is Surgery Necessary for Stage IVB Gastric Cancer Showing Clinical Complete Response to Chemotherapy or Systemic Cancer Therapy?
errAnnals of Surgical Oncology
IF3.5
err2025-12-06
err0
PREAI
errTakumi Habu; Shinpei Ushiyama; Izuma Nakayama; Masahiro Yura; Mitsumasa Yoshida; Naoya Sakamoto; Takeshi Kuwata; Kohei Shitara; Takahiro Kinoshita
errShare
errSave
An open label phase II study of total neoadjuvant therapy (TNT) consisting of FLOT with pembrolizumab and short radiation for patients with locally advanced gastroesophageal junction adenocarcinoma (EPOC2301)
errESMO Gastrointestinal Oncology
IF0
err2025-12-01
err0
errOAAI
errSato, K.; Nakayama, I.; Yura, M.; Sato, A.; Suzuki, M.; Kadota, T.; Nakamura, M.; Sakamoto, N.; Hashimoto, T.; Sakashita, S.; Wakabayashi, M.; Shoji, H.; Hayashi, T.; Daiko, H.; Kato, K.; Yoshino, T.; Yano, T.; Fujita, T.; Kinoshita, T.; Shitara, K.
errShare
errSave
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies
errNature Communications
IF15.7
err2025-11-01
err0
errOAAI
errElizabeth J. Carstens; Kazuki Takahashi; Naoya Sakamoto; Martina De Vizio; Micaela Morgado; Shahryar Khoshtinat Nikkhoi; Abhishek Mangipudi; Canh Hiep Nguyen; Tate Weltzin; Izuma Nakayama; Qiang Lv; Jue Zeng; Cui Nie; Changjing Deng; Xiaoxiao Wang; Lile Liu; Samuel J. Klempner; Anusuya Ramasubramanian; Jonathan A. Nowak; Andrew J. Aguirre; Kohei Shitara; Eric L. Smith
errShare
errSave
Is Surgery Necessary for Stage IVB Gastric Cancer Showing Clinical Complete Response to Chemotherapy or Systemic Cancer Therapy?
errAnnals of Surgical Oncology
IF3.5
err2025-10-30
err0
PREAI
errTakumi Habu; Shinpei Ushiyama; Izuma Nakayama; Masahiro Yura; Mitsumasa Yoshida; Naoya Sakamoto; Takeshi Kuwata; Kohei Shitara; Takahiro Kinoshita
errShare
errSave
Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers
errFuture Oncology
IF2.6
err2025-10-17
err0
errOAAI
errSara Hurvitz; Matteo Simonelli; Ramón Yarza; David Berz; Shigehisa Kitano; Gianluca Del Conte; Daniel Acosta Eyzaguirre; Bernard Gaston Doger de Speville Uribe; Daniela Maier; Damijan Erzen; Sila Aykut Yazgili; Giuseppe Curigliano; Ting Deng; Min Yan; Qingyuan Zhang; Xian Wang; Izuma Nakayama; Kohei Shitara
errShare
errSave
Health-related quality-of-life outcomes with regorafenib in advanced gastric and esophagogastric junction cancer: results from the INTEGRATE trials
errGastric Cancer
IF5.1
err2025-10-10
err0
PREAI
errAndrew J. Martin; Yu Yang Soon; Katrin Marie Sjoquist; Nick Pavlakis; David Goldstein; Kohei Shitara; John R. Simes
errShare
errSave
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: an ARCAD database study
errEuropean Journal of Cancer
IF7.1
err2025-10-02
err0
errOAAI
errKazumasa Yamamoto; Hideaki Bando; Toshihiro Misumi; Tomomi Nishikawa; Masashi Wakabayashi; Kentaro Yamazaki; Yoshihiko Maehara; Eiji Oki; Leonard B Saltz; Jean-Yves Douillard; Cornelis JA Punt; Miriam Koopman; Eric Van Cutsem; Carsten Bokemeyer; Alan P Venook; Volker Heinemann; Chiara Cremolini; J. Randolph Hecht; Hans-Joachim Schmoll; Goro Nakayama; Heinz-Josef Lenz; Thierry Andre; Qian Shi; Aimery de Gramont; Kohei Shitara; Takayuki Yoshino
errShare
errSave
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer
errESMO Open
IF8.3
err2025-09-30
err0
errOAAI
errK. Yamamoto; Y. Owaki; I. Nakayama; N. Sakamoto; M. Ishizaka; T. Kadota; D. Okemoto; Y. Matsubara; Y. Miyashita; A. Kobayashi; U. Okazaki; K. Seguchi; T. Hosokai; T. Ogura; S. Mishima; D. Kotani; A. Kawazoe; T. Hashimoto; Y. Kuboki; H. Bando; T. Kojima; T. Yoshino; T. Kuwata; G. Ishii; T. Yano; K. Shitara
errShare
errSave
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer
errTherapeutic Advances in Medical Oncology
IF4.2
err2025-09-20
err0
errOAAI
errFei Zhang; Izuma Nakayama; Naoya Sakamoto; Dai Okemoto; Amane Jubashi; Yuki Matsubara; Yu Miyashita; Seiya Sato; Shinpei Ushiyama; Akinori Kobayashi; Ukyo Okazaki; Kazumasa Yamamoto; Saori Mishima; Daisuke Kotani; Akihito Kawazoe; Tadayoshi Hashimoto; Yoshiaki Nakamura; Yasutoshi Kuboki; Hideaki Bando; Takashi Kojima; Takayuki Yoshino; Takeshi Kuwata; Kohei Shitara
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
E
Eric Van Cutsem
H-index: 174 · Papers: 1.8K
C
Charles S. Fuchs
H-index: 171 · Papers: 1.7K
J
Jaffer A. Ajani
H-index: 152 · Papers: 1.7K
J
Josep Tabernero
H-index: 146 · Papers: 2.7K
A
Al B. Benson
H-index: 132 · Papers: 813
View more